Compare SGMT & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SGMT | FSFG |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Savings Institutions |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.2M | 221.5M |
| IPO Year | 2023 | 2008 |
| Metric | SGMT | FSFG |
|---|---|---|
| Price | $6.35 | $33.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $29.71 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 504.2K | 11.5K |
| Earning Date | 03-11-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | N/A | ★ 67.68 |
| EPS | N/A | ★ 3.32 |
| Revenue | N/A | ★ $84,223,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | N/A | ★ 23.59 |
| 52 Week Low | $1.73 | $21.63 |
| 52 Week High | $11.41 | $33.46 |
| Indicator | SGMT | FSFG |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 62.45 |
| Support Level | $5.95 | $31.81 |
| Resistance Level | $6.42 | $32.89 |
| Average True Range (ATR) | 0.31 | 0.53 |
| MACD | 0.09 | 0.08 |
| Stochastic Oscillator | 77.04 | 83.69 |
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.